These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1562116)

  • 1. Class III drugs: their effects on arrhythmias and on the QT interval.
    Campbell R; Loaiza A
    Ann N Y Acad Sci; 1992 Jan; 644():223-34. PubMed ID: 1562116
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ventricular cardiac arrhythmias. New anti-arrhythmia agents].
    Scholz H
    Z Kardiol; 1996; 85 Suppl 6():91-6. PubMed ID: 9064988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a combination of class III and class Ic antiarrhythmic agents in patients with electrical storm.
    Fuchs T; Groysman R; Meilichov I
    Pharmacotherapy; 2008 Jan; 28(1):14-9. PubMed ID: 18154469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pink grapefruit juice on QT variability in patients with dilated or hypertensive cardiomyopathy and in healthy subjects.
    Piccirillo G; Magrì D; Matera S; Magnanti M; Pasquazzi E; Schifano E; Velitti S; Mitra M; Marigliano V; Paroli M; Ghiselli A
    Transl Res; 2008 May; 151(5):267-72. PubMed ID: 18433709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Classification and mechanism of action of anti-arrhythmia drugs].
    Gasic S
    Wien Med Wochenschr; 1994; 144(14-15):338-42. PubMed ID: 7825324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of amiodarone, sematilide, and sotalol on QT dispersion.
    Cui G; Sen L; Sager P; Uppal P; Singh BN
    Am J Cardiol; 1994 Nov; 74(9):896-900. PubMed ID: 7526675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arrhythmia control by prolonging repolarization: the concept and its potential therapeutic impact.
    Singh BN
    Eur Heart J; 1993 Nov; 14 Suppl H():14-23. PubMed ID: 7904934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical pharmacology of antiarrhythmic drugs.
    Adams PC; Campbell RW; Julian DG
    Cardiovasc Clin; 1984; 14(3):153-90. PubMed ID: 6722851
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy of atrial fibrillation with class III anti-arrhythmia agents].
    Follath F; Candinas R; Frielingsdorf J
    Herz; 1993 Feb; 18(1):20-6. PubMed ID: 8454249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of class III antiarrhythmic agents in maintaining sinus rhythm.
    Brachmann J
    Europace; 2000 Jul; 1 Suppl C():C10-5. PubMed ID: 11220519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed ventricular repolarization as an anti-arrhythmic principle.
    Vaughan Williams EM
    Eur Heart J; 1985 Nov; 6 Suppl D():145-9. PubMed ID: 2417849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postrepolarization refractoriness: a mechanism in need for a molecule?
    Kirchhof P; Fabritz L
    Heart Rhythm; 2012 Jun; 9(6):983-4. PubMed ID: 22334152
    [No Abstract]   [Full Text] [Related]  

  • 13. Tolerance to the repolarization effects of rac-sotalol during long-term treatment.
    Padrini R; Gusella M; Al Bunni M; Piovan D; Zordan R; Magnolfi G; Maiolino P; Ferrari M
    Br J Clin Pharmacol; 1997 Nov; 44(5):463-70. PubMed ID: 9384463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of amiodarone and cisapride on simulated human ventricular electrophysiology and electrocardiograms.
    Wilhelms M; Rombach C; Scholz EP; Dössel O; Seemann G
    Europace; 2012 Nov; 14 Suppl 5():v90-v96. PubMed ID: 23104920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postrepolarization refractoriness in acute ischemia and after antiarrhythmic drug administration.
    Pandit SV; Noujaim SF; Jalife J
    Heart Rhythm; 2012 May; 9(5):e13-4; author reply e14. PubMed ID: 22426151
    [No Abstract]   [Full Text] [Related]  

  • 16. Is there a need for new antiarrhythmic drugs?
    Roden DM
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():13-8. PubMed ID: 8734158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiarrhythmic drugs: present and future.
    Sharma S
    J Assoc Physicians India; 2007 Apr; 55 Suppl():43-6. PubMed ID: 18368867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Harmful interactions of amiodarone and class I anti-arrhythmia agents].
    Tartini R; Kappenberger L; Steinbrunn W
    Schweiz Med Wochenschr; 1982 Nov; 112(45):1585-7. PubMed ID: 7156952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QT prolongation and serum sotalol concentration are highly correlated following intravenous and oral sotalol.
    Somberg JC; Preston RA; Ranade V; Molnar J
    Cardiology; 2010; 116(3):219-25. PubMed ID: 20693799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New anti-arrhythmia agents].
    Honerjäger P; Schmidt G
    Z Kardiol; 1992; 81 Suppl 4():133-7. PubMed ID: 1363260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.